ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.210,48
0,58%
S&P 500
5.187,70
0,13%
US Dollar vs BRL
5,0748
-0,03%
Bitcoin
62.505,22
-1,05%
Brent Oil
82,865
-0,73%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Vericel Corporation (VCEL)

  7. Vericel Corporation (VCEL) Notícias

VCEL

Vericel (VCEL)

Vericel Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:VCEL
DataHoraFonteTítuloCódigoCompanhia
24/04/202409:30GlobeNewswire Inc.Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024NASDAQ:VCELVericel Corporation
11/03/202417:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VCELVericel Corporation
11/03/202417:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCELVericel Corporation
29/02/202411:04Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VCELVericel Corporation
29/02/202410:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCELVericel Corporation
29/02/202409:55GlobeNewswire Inc.Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial GuidanceNASDAQ:VCELVericel Corporation
27/02/202410:30GlobeNewswire Inc.Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024NASDAQ:VCELVericel Corporation
15/02/202410:30GlobeNewswire Inc.Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024NASDAQ:VCELVericel Corporation
14/02/202409:42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VCELVericel Corporation
13/02/202408:01Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:VCELVericel Corporation
05/02/202410:30GlobeNewswire Inc.Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024NASDAQ:VCELVericel Corporation
09/01/202409:55GlobeNewswire Inc.Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial ResultsNASDAQ:VCELVericel Corporation
03/01/202410:30GlobeNewswire Inc.Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024NASDAQ:VCELVericel Corporation
08/12/202318:39Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:VCELVericel Corporation
08/11/202311:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCELVericel Corporation
08/11/202309:55GlobeNewswire Inc.Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial GuidanceNASDAQ:VCELVericel Corporation
07/11/202310:30GlobeNewswire Inc.Vericel to Present at the Stephens Annual Investment ConferenceNASDAQ:VCELVericel Corporation
25/10/202309:30GlobeNewswire Inc.Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023NASDAQ:VCELVericel Corporation
28/09/202309:30GlobeNewswire Inc.Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBridNASDAQ:VCELVericel Corporation
20/09/202317:30GlobeNewswire Inc.Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in AdultsNASDAQ:VCELVericel Corporation
06/09/202309:30GlobeNewswire Inc.Vericel to Present at the Morgan Stanley Global Healthcare ConferenceNASDAQ:VCELVericel Corporation
02/08/202308:55GlobeNewswire Inc.Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial GuidanceNASDAQ:VCELVericel Corporation
20/07/202309:30GlobeNewswire Inc.Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023NASDAQ:VCELVericel Corporation
26/06/202317:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VCELVericel Corporation
22/06/202316:17Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:VCELVericel Corporation
22/05/202317:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VCELVericel Corporation
10/05/202309:50Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VCELVericel Corporation
10/05/202308:55GlobeNewswire Inc.Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial GuidanceNASDAQ:VCELVericel Corporation
05/05/202317:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VCELVericel Corporation
02/05/202310:00PR Newswire (US)Dimension Inx announces the addition of biotech industry leaders Paul K. Wotton, Ph.D., as Board Director and Chris Ehrlich as Senior AdvisorNASDAQ:VCELVericel Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:VCEL

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
NGRD3
Neogrid Participacoes ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
PRIO3
PETRORIO ON
BOV
AZEV4
AZEVEDO PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
IRBR3
IRB BRASIL ON
BOV
HAGA3
HAGA ON
BOV
OIBR3
OI ON
BOV
TPIS3
TRIUNFO PART ON
BOV
BRKM5
BRASKEM PNA
BOV
VVEO3
CM Hospitalar ON
BOV
TELB4
TELEBRAS PN
BOV
MNPR3
MINUPAR ON
BOV
AGXY3
Agrogalaxy Participacoes ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados